PAMELA BYRNE: Open Payments
NPI 1881459196 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 14 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $108 |
| Lilly USA, LLC | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Exact Sciences Corporation | 2 | $31 |
| Dexcom, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: UBRELVY, MOUNJARO, QULIPTA, AIRSUPRA, VRAYLAR, Dexcom G6 Transmitter, Cologuard Collection Kit, JARDIANCE.
Industry payments across MO — which companies pay providers there.
